Key result
The COVID-19 outbreak was associated with a reduction in the incidence rate of PCI for acute coronary syndromes from 178 to 120 cases per 100,000 residents per year (IRR 0.68).
Why the study?
Does the COVID-19 outbreak reduce the incidence rate of percutaneous coronary interventions for acute coronary syndromes?
Observational (n=1,093)
Yes
Does the COVID-19 outbreak reduce the incidence rate of percutaneous coronary interventions for acute coronary syndromes?
Relative Risk: 0.68
Absolute Event Rate: 120% vs 178%
The COVID-19 outbreak was associated with a significant reduction in PCI rates for acute coronary syndromes, highlighting a concerning decline in hospital admissions for life-threatening cardiac events.
No takes yet. Share an insight, caveat, or question.
May signal missed ACS during outbreaks; leaves open mechanisms and need for prospective studies before changing practice.
Piccolo et al. (2020) conducted an observational in Acute Coronary Syndromes (n=1,093). COVID-19 outbreak vs. 4-week period before the COVID-19 outbreak was evaluated on Incidence rate of PCI for ACS (cases per 100,000 residents per year) (IRR 0.68). The COVID-19 outbreak was associated with a reduction in the incidence rate of PCI for acute coronary syndromes from 178 to 120 cases per 100,000 residents per year (IRR 0.68).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: